News for Iovance Biotherapeutics Stock (IOVA)

Biotech Stock Surges on FDA Update

Schaeffers Research • 05/30/23

Iovance Biotherapeutics shares rally on receiving FDA priority review for melanoma drug

Proactive Investors • 05/30/23

FDA Accepts Iovance's (IOVA) BLA Filing for Melanoma Drug

Zacks Investment Research • 05/29/23

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

GlobeNewsWire • 05/26/23

Iovance (IOVA) Posts Narrower-Than-Expected Loss in Q1

Zacks Investment Research • 05/10/23

Iovance Biotherapeutics, Inc. (IOVA) Q1 2023 Earnings Call Transcript

Seeking Alpha • 05/10/23

Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

GlobeNewsWire • 05/09/23

Iovance Biotherapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, May 9, 2023

GlobeNewsWire • 05/02/23

Iovance: Completion Of BLA Submission Brings Substantial Catalysts

Seeking Alpha • 04/24/23

Iovance Progresses Despite Challenges In Developing Potency Assays For Lifileucel

Seeking Alpha • 04/23/23

Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon

The Motley Fool • 04/20/23

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)

PRNewsWire • 04/19/23

Iovance Biotherapeutics: Looking Towards Successful FDA Review In 2023

Seeking Alpha • 04/19/23

Why Is Iovance Biotherapeutics (IOVA) Down 9.2% Since Last Earnings Report?

Zacks Investment Research • 03/30/23

Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug

Zacks Investment Research • 03/27/23

Iovance Biotherapeutics completes license application submission for advanced melanoma therapy; shares rally

Market Watch • 03/24/23

Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma

GlobeNewsWire • 03/24/23

Iovance (IOVA) Q4 Earnings In Line With Estimates, Revenues Nil

Zacks Investment Research • 03/01/23

Iovance Biotherapeutics, Inc. (IOVA) Q4 2022 Earnings Call Transcript

Seeking Alpha • 03/01/23

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

GlobeNewsWire • 02/28/23

Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, February 28, 2023

GlobeNewsWire • 02/21/23

Iovance: Capturing A Lucrative Market

Seeking Alpha • 02/01/23

Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%

Zacks Investment Research • 01/24/23

Why Iovance Biotherapeutics Stock Soared 12% Higher Today

The Motley Fool • 01/23/23

Iovance Biotherapeutics Provides Corporate, Clinical, and Regulatory Updates

GlobeNewsWire • 01/23/23